Buy & Sell Orion Office REIT Inc (ONL) – Orion Office REIT Inc Price Today
Aura AI Summary
Key Stats
- $158.56MMarket Cap
- Real EstateSector
- -17.52%3M Drawdown
- $642.21MEnterprise Value
- 2.87%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 29 daysTypical Hold Time
Orion Office REIT Inc (ONL) is currently valued at a market capitalization of $158.56M, with an enterprise value of $642.21M. Over the past 52 weeks, Orion Office REIT Inc has traded between a low of $1.91 and a high of $3.04, highlighting its annual price range. Over the past three months, Orion Office REIT Inc has recorded a drawdown of -17.52%, reflecting recent price volatility. Orion Office REIT Inc offers a dividend yield of 2.87%, with the most recent dividend of $0.02 paid on 31 Mar 26. On average, investors hold Orion Office REIT Inc for approximately 29 days, indicating typical investor behavior on the platform.
About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Most Recent News
Nvidia's CEO runs the $5T company with urgency, fearing collapse in 30 days, says Perplexity's CEO.
Perplexity AI CEO Aravind Srinivas shared lessons from Nvidia's Jensen Huang and Tesla's Elon Musk, highlighting Huang's mindset of running Nvidia as if it could fail within 30 days despite its $5 trillion valuation and advanced technology. Srinivas ...

Meta launches AI-powered Facebook Search tool aiming to generate $10B annually and challenge Google.
Meta Platforms introduced an AI-powered feature called "AI Mode" within Facebook Search, which uses Meta's AI model Muse Spark to provide answers from public content rather than traditional search results. This innovation could generate over $10 bill...

Cuprina Holdings shares drop 22% after a 112% intraday rally on FDA clearance news.
Cuprina Holdings shares surged 111.84% intraday following FDA 510(k) clearance for its MEDIFLY Maggots wound care product, the first maggot debridement therapy using Lucilia cuprina species approved in the U.S. The product treats non-healing necrotic...
